Article Topic
PSM asks congress for domain name reforms to stop COVID-19 and other healthcare scams
Last week PSM asked Congress to help protect the public from online COVID-19 scams by requiring domain name sellers to suspend and lock websites that facilitate health fraud and re-opening registration information so that law enforcement can pursue criminals using websites to take advantage of the public.
[...]#covidscams episode for May 13, 2020: Financial Scams
As we’ve focused these last few weeks on COVID-19 scams related to medicine and medical supplies, however, another population of scammers has been exploiting Americans. This week we’re calling out financially-focused covidscams, which comprise a large part of the $13.4 million that U.S. citizens have lost to fraud since the beginning of the year.
[...]FDA Alert: MasterPharm, LLC. Issues Voluntary Nationwide Recall of Finasteride Plus 1.25mg Due to the Presence of an Undeclared Antihypertensive Drug
This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. May 11, 2020 Company Contact Information Consumers: Lin Leung, MasterPharm, LLC Phone: (866) 630-5600 Email: recall@masterpharm.com…
[...]Counterfeit Medicine News for the Week of May 4, 2020
PSM is still monitoring public reports of dangerous counterfeit medical supplies and treatments. Here’s a quick round-up of counterfeit news published the week May 4, 2020.
[...]#covidscams episode for May 6, 2020: Domain Name Reform
Law enforcement is encountering problems kicking COVID-19 scammers offline. Learn how, and how we can fix it.
[...]Research Study Confirms That Cheap And Safe Drug Importation Is Not Feasible
Research Study Confirms That Cheap And Safe Drug Importation Is Not Feasible Read the abstract for Dr. Acri’s article. In March 2020, the Journal of Pharmaceutical Health Services Research, an official journal of the Royal Pharmaceutical Society, published a study by Dr. Kristina M.L. Acri née Lybecker titled “State Pharmaceutical Importation Programmes: An Analysis of…
[...]Counterfeit Medicine News for the Week of April 27, 2020
Even as the COVID-19 pandemic unfolds, PSM is keeping a steady eye on public reports of dangerous counterfeit drugs. Here’s a quick round-up of counterfeit news published the week of April 27th, 2020.
[...]Freedom Of Access Act Response From The State of Maine
In June 2019, the governor of Maine signed into law LD 1272, a bill that would allow the state to establish a wholesale Canadian prescription drug importation program. On April 13, 2020, the Partnership for Safe Medicines (PSM) filed a request to receive copies of all submitted responses to Maine’s Request for Comment (RFC) for…
[...]April 29, 2020 episode: After 114 years of protecting Americans, the FDA is still hard at work—on #COVIDscams
The FDA was established to protect Americans from adulterated food and medicines and from criminals selling ineffective, outrageous, and sometimes harmful treatments. Unfortunately, fake cures are fertile ground for profiteers, and no matter how many products the FDA seizes, more crop up. In the wake of the COVID-19 pandemic the FDA has been working overtime to stop the sale of harmful and ineffective COVID “treatments.” This week PSM did some research in the FDA’s warning letter archives to survey fake COVID-19 cures.
[...]#covidscams episode for April 22, 2020
In this edition: Senators take up ASOP’s Call To Arms on domain name scams, more fake test kits, and the nearly infinite pool of #covidscam domain names.
[...]